arrow
Å

Åke Borg

Lund University
H指数:107
被引数:5.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer

原发ER阳性、HER2阴性乳腺癌中的同源重组缺陷

2026-02-160
OAAI
Clinical potential of whole-genome data linked to mortality statistics in patients with breast cancer in the UK: a retrospective analysis

英国乳腺癌患者全基因组数据与死亡率统计数据的关联:一项回顾性分析

2025-10-070
OAAI
Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer

超过4600名疑似遗传性乳腺癌和卵巢癌妇女的扩展遗传分析和肿瘤特征

2023-08-105
OAAI
Obesity-associated changes in molecular biology of primary breast cancer

原发性乳腺癌与肥胖相关的分子生物学改变

2023-07-2113
OAAI
Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points-based ACMG/AMP approach

临床,剪接和功能分析以分类BRCA2外显子3变体: 基于点的ACMG/AMP方法的应用

2022-10-236
OAAI
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
2022-08-1635
OAAI
Merged testing for colorectal cancer syndromes and re-evaluation of genetic variants improve diagnostic yield: Results from a nationwide prospective cohort

结直肠癌综合征的合并检测和遗传变异的重新评估可提高诊断率: 来自全国范围的前瞻性队列的结果

2022-05-021
OA
The association between genomic alterations and body mass index in patients with early breast cancer

早期乳腺癌患者基因组改变与体重指数的关系

2022-02-150
PRE
Nordictrip, a translational randomized phase-3study exploring the effect of the addition of capecitabine to carboplatinum-based chemotherapy in early triple negative breast cancer, ClinicalTrials.gov Identifier: NCT04335669
2022-02-150
PRE
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants

携带BRCA1和BRCA2致病错义变异体的女性与携带蛋白截断变异体的女性相比,患乳腺癌和卵巢癌的风险

2022-01-0117
OAAI